We serve Chemical Name:5-oxo-7,8-dihydro-6H-naphthalene-1-carboxylic acid CAS:56461-21-3 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:5-oxo-7,8-dihydro-6H-naphthalene-1-carboxylic acid
CAS.NO:56461-21-3
Synonyms:5,6,7,8-Tetrahydro-5-oxo-1-naphthoesaeure;5-oxo-5,6,7,8-tetrahydro-naphthalene-1-carboxylic acid
Molecular Formula:C11H10O3
Molecular Weight:190.19500
HS Code:
Physical and Chemical Properties:
Melting point:N/A
Boiling point:393.932ºC at 760 mmHg
Density:1.309 g/cm3
Index of Refraction:
PSA:54.37000
Exact Mass:190.06300
LogP:1.90380
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 5,6,7,8-Tetrahydro-5-oxo-1-naphthoesaeure chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,5-oxo-5,6,7,8-tetrahydro-naphthalene-1-carboxylic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,5-oxo-5,6,7,8-tetrahydro-naphthalene-1-carboxylic acid Use and application,5-oxo-5,6,7,8-tetrahydro-naphthalene-1-carboxylic acid technical grade,usp/ep/jp grade.
Related News: “We welcome a formal review into the interactions between the FDA and Biogen on the path to the approval of aducanumab,” Sandrock said. “A better understanding of the facts is good for everyone involved to assure confidence in both the therapy and the process by which it was approved as we prioritize the issues that affect patients.” 2H-Perfluoro-5,8-dimethyl-3,6,9-trioxadodecane manufacturers For skin rash, the difference in response rates for anifrolumab versus placebo at week 52 were 13.5% SLE Disease Activity Index (SLEDAI), 15.5% British Isles Lupus Assessment Group index (BILAG) and 15.6% modified Cutaneous Lupus Erythematosus Disease Area and Severity Index (mCLASI). For arthritis, differences in response rates were 8.2% SLEDAI, 11.8% BILAG and 12.6% joint response. 1,2,3,4-Tetrahydro-7-isoquinolinol suppliers In taking control of Vanamali, Wavelength will double the firm’s production capacity and add more than 10 key regulatory starting materials and drug intermediates for Wavelength’s own strategic APIs and API CDMO customers, a Wavelength spokeswoman said by email. methyl 2-cyano-5-methoxy-3-methylbenzoate vendor & factory.
